Page last updated: 2024-09-02

triptolide and Osteoporosis

triptolide has been researched along with Osteoporosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Huang, Z; Lian, K; Lin, D; Luo, D; Ren, H; Xian, H; Zhang, H; Zhang, P1
Wang, B; Wang, Y; Yang, X1
Park, B1

Reviews

1 review(s) available for triptolide and Osteoporosis

ArticleYear
The Study of Cellular Mechanism of Triptolide in the Treatment of Cancer, Bone Loss and Cardiovascular Disease and Triptolide's Toxicity.
    Current stem cell research & therapy, 2020, Volume: 15, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Arthritis, Rheumatoid; Autophagy; Cardiovascular Diseases; Diterpenes; Epoxy Compounds; Humans; Medicine, Chinese Traditional; Neoplasms; Osteoporosis; Phenanthrenes; Plant Extracts; Signal Transduction; Tripterygium

2020

Other Studies

2 other study(ies) available for triptolide and Osteoporosis

ArticleYear
The protective effects of triptolide on age-related bone loss in old male rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 98

    Topics: Animals; Bone Resorption; Diterpenes; Epoxy Compounds; Male; Osteoclasts; Osteoporosis; Phenanthrenes; Rats; Rats, Sprague-Dawley

2018
Triptolide, a diterpene, inhibits osteoclastogenesis, induced by RANKL signaling and human cancer cells.
    Biochimie, 2014, Volume: 105

    Topics: Animals; Bone Resorption; Cell Differentiation; Cell Line, Tumor; Diterpenes; Epoxy Compounds; Humans; Mice; Neoplasms; Osteoclasts; Osteoporosis; Phenanthrenes; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction

2014